Lisa M Barker

We don’t have enough information about this author to calculate their statistics. If you think this is an error let us know.
Learn More
PURPOSE The overall survival (OS) of patients with relapsed Ewing's sarcoma family of tumors (ESFT) is poor, and the relative benefit of high-dose therapy (HDT) is controversial. PATIENTS AND METHODS We retrospectively identified 55 consecutive ESFT patients with adequate medical records for review, who were treated at Children's Hospital and Regional(More)
  • 1